532067 Stock Overview
3B BlackBio Dx Limited engages in the design, development, manufacturing, and commercialization of PCR based molecular diagnostic kits, PCR enzymes, and PCR reagents in India.
Snowflake Score | |
---|---|
Valuation | 2/6 |
Future Growth | 0/6 |
Past Performance | 5/6 |
Financial Health | 6/6 |
Dividends | 3/6 |
3B Blackbio Dx Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | ₹736.00 |
52 Week High | ₹924.00 |
52 Week Low | ₹390.00 |
Beta | 1.38 |
1 Month Change | -1.06% |
3 Month Change | -6.85% |
1 Year Change | 70.13% |
3 Year Change | 60.33% |
5 Year Change | 743.55% |
Change since IPO | 4,307.19% |
Recent News & Updates
Recent updates
Shareholder Returns
532067 | IN Chemicals | IN Market | |
---|---|---|---|
7D | -6.4% | -2.0% | -1.6% |
1Y | 70.1% | 16.5% | 45.0% |
Return vs Industry: 532067 exceeded the Indian Chemicals industry which returned 16.5% over the past year.
Return vs Market: 532067 exceeded the Indian Market which returned 45% over the past year.
Price Volatility
532067 volatility | |
---|---|
532067 Average Weekly Movement | 6.3% |
Chemicals Industry Average Movement | 6.4% |
Market Average Movement | 6.9% |
10% most volatile stocks in IN Market | 10.1% |
10% least volatile stocks in IN Market | 4.2% |
Stable Share Price: 532067 has not had significant price volatility in the past 3 months.
Volatility Over Time: 532067's weekly volatility (6%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1972 | 49 | Dhirendra Dubey | 3bblackbio.com |
3B BlackBio Dx Limited engages in the design, development, manufacturing, and commercialization of PCR based molecular diagnostic kits, PCR enzymes, and PCR reagents in India. Its se11s its PCR based molecular diagnostic kits under the TRUPCR brand to diagnostics labs. The company also offers lateral flow assays under the brand name of TRURAPID and the NGS assays under the brand name of TRUNGS.
3B Blackbio Dx Limited Fundamentals Summary
532067 fundamental statistics | |
---|---|
Market cap | ₹6.32b |
Earnings (TTM) | ₹316.57m |
Revenue (TTM) | ₹787.29m |
20.0x
P/E Ratio8.0x
P/S RatioIs 532067 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
532067 income statement (TTM) | |
---|---|
Revenue | ₹787.29m |
Cost of Revenue | ₹209.12m |
Gross Profit | ₹578.17m |
Other Expenses | ₹261.60m |
Earnings | ₹316.57m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | 36.88 |
Gross Margin | 73.44% |
Net Profit Margin | 40.21% |
Debt/Equity Ratio | 0.6% |
How did 532067 perform over the long term?
See historical performance and comparison